Publication: Prevalence and predictors of carotid stenosis in Thai patients with ocular disorders
Issued Date
2013-01-01
Resource Type
ISSN
15322653
09675868
09675868
Other identifier(s)
2-s2.0-84891871421
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Clinical Neuroscience. Vol.20, No.6 (2013), 862-866
Suggested Citation
Disya Ratanakorn, Narumon Kongsakorn, Jesada Keandoungchun, Charles H. Tegeler Prevalence and predictors of carotid stenosis in Thai patients with ocular disorders. Journal of Clinical Neuroscience. Vol.20, No.6 (2013), 862-866. doi:10.1016/j.jocn.2012.02.046 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/32631
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Prevalence and predictors of carotid stenosis in Thai patients with ocular disorders
Other Contributor(s)
Abstract
There are limited data on prevalence and predictors of carotid stenosis (CS) in Thai and Asian patients with ocular disorders. A total of 135 of 2849 patients enrolled in the Neurosonology Registry had an ocular indication (OI). Demographics, the nature of the OI, risk factors (RF), presence of CS >50% and non-stenotic carotid plaque (NSCP) were analyzed. The mean age of patients was 60.40 ± 14.02 years. The RF included hypertension (47.4%), hypercholesterolemia (34.07%), diabetes mellitus (DM) (31.11%) and current smoking (41.48%). NSCP was found in 20% of Thai patients withOD. CS was found in 11.11% (ipsilateral 10.37%). Predictors of CS were ocular ischemic syndrome (odds ratio [OR] 19.63,p = 0.000), retinal artery occlusion (OR 14.13, p = 0.000), anterior ischemic optic neuropathy (OR 9.75, p = 0.002), neovascularized glaucoma (OR 8.15, p = 0.018), and DM (OR 2.53, p = 0.037). The presence of CS (11.11%), and CS or NSCP (31%) are markers of atherosclerotic risk. The nature of the OI predicted carotid findings. Carotid ultrasound helps to identify the risk for cardiovascular events and should be considered in patients with OI. © 2012 Elsevier Ltd. All rights reserved.